Tag: Multiple myeloma

Natco Pharma launches PrNAT-LENALIDOMIDE Capsules in Canada

businessnewstoday- September 29, 2021 0

Natco Pharma Limited has announced the Canadian launch of PrNAT-LENALIDOMIDE Capsules, a generic version of Celgene Corporation’s cancer drug Revlimid. The launch was announced earlier ... Read More

Aurobindo subsidiary Eugia gets FDA approval for Cyclophosphamide Injection

businessnewstoday- August 28, 2021 0

Aurobindo Pharma said that its subsidiary Eugia Pharma Specialities has secured approval from the US Food and Drug Administration (FDA) for the new drug application ... Read More

Pfizer to acquire immuno-oncology company Trillium Therapeutics for $2.2bn

businessnewstoday- August 27, 2021 0

US pharma giant Pfizer has agreed to acquire Trillium Therapeutics, a publicly listed Canadian clinical stage immuno-oncology company, for $18.5 per share or $2.26 billion ... Read More

Sun Pharma to settle patent litigation with Celgene for generic Revlimid

businessnewstoday- June 22, 2021 0

Sun Pharmaceutical Industries (Sun Pharma) along with one of its fully-owned subsidiaries has reached an agreement with Celgene, a fully-owned subsidiary of Bristol Myers Squibb, ... Read More

Natco Pharma gets FDA approval for Carfilzomib Vials ANDA

businessnewstoday- June 20, 2021 0

Natco Pharma Limited said that its marketing partner - Breckenridge Pharmaceutical Inc. (BPI), has secured approval from the US Food and Drug Administration (FSA) for ... Read More

Natco Pharma gets FDA approval for Lenalidomide Capsules

businessnewstoday- May 24, 2021 0

Natco Pharma has secured the final approval from the US Food and Drug Administration (FDA) of its abbreviated new drug application (ANDA) for Lenalidomide Capsules, ... Read More

BMS, bluebird bio bag Abecma FDA approval for multiple myeloma in adults

businessnewstoday- March 28, 2021 0

Abecma FDA approval : Bristol Myers Squibb (BMS) and bluebird bio have secured approval from the US Food and Drug Administration (FDA) for Abecma (idecabtagene ... Read More

Takeda’s NINLARO fails to meet PFS primary endpoint in TOURMALINE-MM2 trial

pharmanewsdaily- September 11, 2020 0

Takeda Pharmaceutical said that the Phase 3 TOURMALINE-MM2 trial in newly diagnosed multiple myeloma patients for NINLARO (ixazomib) in addition to lenalidomide and dexamethasone failed ... Read More

Janssen, Amgen secure FDA approval for DKd regiment in multiple myeloma

pharmanewsdaily- August 23, 2020 0

DKd regiment FDA approval for multiple myeloma : Janssen Pharmaceutical Companies of Johnson & Johnson and Amgen have been granted an expanded approval from the ... Read More

Cellectis begins MELANI-01 clinical trial for UCARTCS1 in multiple myeloma

pharmanewsdaily- October 30, 2019 0

Cellectis said that it has dosed the first patient in a phase 1  study - the MELANI-01 clinical trial to evaluate UCARTCS1, an allogeneic off-the-shelf ... Read More